AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02372786 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 2,5% lidocaine / 2,5% prilocaine cream
Description: The treatment area will be divided in two equal parts with white markings. Between these two areas an area of 1 cm will be marked. This area will be left untreated, to avoid possible spill-over effects of the two anaesthetic creams. A thick layer of 2,5% lidocaine / 2,5% prilocaine cream will be applied on one side to the intact skin under plastic occlusion (average of 1,5-2g per 10 cm2) 60 minutes before laser treatment.
Study NCT03338491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Induction of Implemental Mindset
Description: This induction of a psychological state was extensively studied in basic cognitive science. Gollwitzer \& Keller (2016, p.3): The implemental mindset is evoked by asking participants to think of a personal project for which they have already made the decision to act but did not initiate any action yet. Subsequently, participants are asked to list the steps necessary for successful goal attainment and to plan out in detail when, where, and how they intend to act on each of these steps.
Study NCT03338491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Induction of Deliberative Mindset
Description: This induction of a psychological state was extensively studied in basic cognitive science. Gollwitzer \& Keller (2016, p.3): The deliberative mindset is evoked by asking participants to (a) name an unresolved, important personal problem that is causing rumination but for which they have not made a decision yet and (b) reflect on whether to take action or not. Further, to enhance the depth of reflection, participants are requested to list a number of positive and negative, short- and long-term consequences of both deciding to act and deciding not to act; indicating the probability of the occurrence of each of these consequences is required.
Study NCT02372786 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 7% lidocaine / 7% tetracaine cream
Description: The treatment area will be divided in two equal parts with white markings. Between these two areas an area of 1 cm will be marked. This area will be left untreated, to avoid possible spill-over effects of the two anaesthetic creams. A thin layer of 7% lidocaine / 7% tetracaine cream (1mm) will be applied on the other side to the intact skin (average of 1,3g Pliaglis per 10 cm2) 60 minutes before laser treatment.
Study NCT02372786 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Neodymium-doped yttrium aluminium garnet (Nd:Yag) laser
Description: Acne keloidalis nuchae: during this study a 1064 nm Nd:yag laser with a spot size of 7-10 mm, and a fluence of 35-60J/cm2, (depending on the effective and safe clinical response), a pulse duration of 20-35 ms and 2 passes will be used.
Study NCT02372786 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Q-switched nd Yag laser
Description: Tattoo removal: we will use a 3 mm spotsize and a fluence depending on the absorption of the laser light, which is visible as skin whitening.
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nitrofurantoin monohydrate/macrocrystalline capsules
Description: 1 week course of preoperative nitrofurantoin monohydrate/macrocrystalline capsules 100 milligrams twice daily
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ampicillin
Description: IV (2 g)
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ampicillin
Description: IV (2 g)
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gentamicin
Description: IV (5 mg/kg)
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gentamicin
Description: IV (5 mg/kg)
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vancomycin
Description: IV (1 g)
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vancomycin
Description: IV (1 g)
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ceftriaxone
Description: IV (2 g)
Study NCT02384200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ceftriaxone
Description: IV (2 g)
Study NCT01728935 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tenofovir disoproxil
Description: Tenofovir disoproxil 300mg daily
Study NCT00852267 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Carbohydrate, High Saturated Fat Diet
Description: 50% Carbohydrate; 12% Protein; 38% Fat (15% Saturated Fat; 15% Monounsaturated Fat)
Study NCT00852267 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Carbohydrate, High Saturated Fat Diet
Description: 31% Carbohydrate; 31% Protein; 38% Fat (15% Saturated Fat; 14% Monounsaturated Fat)
Study NCT00852267 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Carbohydrate, Low Saturated Fat Diet
Description: 31% Carbohydrate; 31% Protein; 38% Fat (8% Saturated Fat; 21% Monounsaturated Fat)
Study NCT00998621 — intervention group
Intervention type: OTHER
Intervention: Adherence questionnaire
Description: Adherence questionnaire
Study NCT03622242 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pain threshold index
Description: In pain threshold index monitor, monitor patients' pain threshold index based on electroencephalography and adjust infusion rate of remifentanil and propofol according to pain threshold index
Study NCT01268462 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: For nebulization of radioaerosol with oxygen, we used a noninvasive delivery system that consists of a mask with two nontoxic orofacial unidirectional valves - inspiratory and expiratory branch - connected to the nebulizer for radioisotopes Venticis ® II Medical device, class II, CE 0459 (Ventibox / CIS Bio International, France). We used a PEP valve without resistance.
Study NCT04334122 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument-assisted soft tisue mobilization
Description: All patients in the experimental group were given a traditional physiotherapy program applied in lumbar disc herniation for 4 weeks (20 sessions) and 5 days a week.~In addition to the traditional physiotherapy program, the patients in the experimental group were subjected to tool-assisted soft tissue mobilization 3 times a week (12 sessions with 1 day interval).~All evaluations were repeated to all patients in the experimental and control groups after four weeks.
Study NCT04334122 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional physiotherapy
Description: All patients in the control group were given a traditional physiotherapy program applied in lumbar disc herniation for 4 weeks (20 sessions) and 5 days a week.
Study NCT04540172 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Mahur tune, one of the nonverbal instruments of the Traditional Turkish Music Authorities, was selected for the study with the opinion of a music therapy specialist.
Study NCT04540172 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Exercise
Description: In this study, the steps of applying progressive muscle relaxation exercise were created with the guidance of the Relaxation Exercises  materials of the Turkish Psychological Association.
Study NCT00384813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project ASPIRE Home-Based Family Intervention
Description: Home-based psychoeducational family intervention jointly conducted by psychology postdoctoral fellow and respiratory therapist over 4 months
Study NCT00384813 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Project ASPIRE Enhanced Treatment As Usual
Description: Psychoeducational family intervention addressing the written asthma action plan during a single home visit, conducted by a respiratory therapist
Study NCT01764607 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: Patients randomized to this arm of the study will receive sirolimus from the time of randomization at least until 5 weeks or the removal of the skin tumor. Nephrology will determine/manage the immunosuppressant therapy.
Study NCT03622242 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wavelet index
Description: In wavelet index monitor, monitor patients' wavelet index based on electroencephalography as an indicator of depth of anesthesia and adjust infusion rate of propofol according to wavelet index
Study NCT02273349 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lung Volume Reduction Coil (PneumrX Inc.)
Description: Endoscopic Lung Volume Reduction
Study NCT01536522 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional approach for asthma
Description: participants will be provided a medium chain triglyceride supplement or placebo
Study NCT01536522 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Nutritional approach for asthma
Description: participants will be provided a medium chain triglyceride supplement or placebo
Study NCT01536522 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Low Caloric Shake
Description: participants will be provided a low caloric dietary shake
Study NCT01536522 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: whole lung allergen challenge
Description: inhalation of allergens by allergic patients with or without asthma, will be used to define mechanisms underlying the development of airway inflammation
Study NCT01975129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vagitocin
Study NCT02570399 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Oligometastatic patients with abdominal-pelvic lymph nodes
Description: Hypofractionated ablative radiation therapy for oligometastatic patients with lymph node metastases
Study NCT02003248 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial magnetic resonance guided focused ultrasound pallidotomy
Description: Focused ultrasound is an attractive method for non-invasive thermal ablation of soft tissue, including functional brain targets. Treatment begins by acquiring a series of MR images of the target organ. The physician then identifies a target volume in the MR images, and delineates the treatment contours on the images. Therapy planning software calculates the parameters required to effectively treat the defined target volume. During the treatment, an ultrasound transducer generates a point of focused ultrasound energy, called a sonication. The sonication raises the tissue temperature within a well-defined region, enabling neurophysiological assessment in the low range, and thermal coagulation at higher ranges. MR images acquired during sonication provide a quantitative, real-time temperature map of the target area to confirm the location of the sonication and the size of the affected region.
Study NCT01151501 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: noninvasive positive pressure ventilation
Description: Patients in whom the spontaneous breathing trial fail and in whom exclusion criteria are not present during this period were randomly allocated. Patients who are randomized to NPPV goup will be extubated and non-invasive ventilation (BiPAP Vision, Respironics Inc., Murrysville，Pennsylvania) will be delivered immediately after extubation using spontaneous/timed (S/T) mode. Expiratory positive airways pressure (PEEP) was initially set at 4 cmH2O and gradually increased to 6-8 cmH2O or more；and fraction of inspired oxygen (FiO2) was set to achieve pulse oximeter oxygen saturation (SpO2) >92% in cooperation with PEEP. On condition that tidal volume is no less than 6ml/kg，continuous positive airway pressure (CPAP) is permitted to apply，in which the adjusting procedures of CPAP and FiO2 is similar with PEEP and FiO2 in S/T mode. NPPV is terminated When patients can spontaneously breath oxygen provided by a Venturi device at FiO2≤0.35 for more than 24 hours with SpO2>92%.
Study NCT01068418 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D (cholecalciferol)
Description: cholecalciferol 15,000 IU daily for 30 days
Study NCT04575415 — intervention group
Intervention type: DRUG
Intervention: Bevacizumab
Description: Bevacizumab 15mg/kg or clinical routine dose by intravenous drip infusion on day 1 of a 21-day cycle
Study NCT04575415 — intervention group
Intervention type: DRUG
Intervention: Erlotinib
Description: Erlotinib 150mg, orally once a day
Study NCT04575415 — intervention group
Intervention type: DRUG
Intervention: Gefitinib
Description: Gefitinib 250mg, orally once a day
Study NCT03622242 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wavelet index
Description: In wavelet index monitor, monitor patients' wavelet index based on electroencephalography as an indicator of depth of anesthesia and adjust infusion rate of propofol according to wavelet index
Study NCT03321175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: subcutaneous saline irrigation
Description: 200 cc saline irrigation
Study NCT01648075 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Experimental: Probiotic enriched milk
Description: Milk will be enriched with lactobacillus rhamnosus for the experimental group.
Study NCT01648075 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Experimental: Probiotic enriched milk
Description: Milk will be enriched with lactobacillus rhamnosus for the experimental group.
Study NCT03385109 — intervention group
Intervention type: DEVICE
Intervention: Surgery
Description: Patients are approached surgically with the Senhance Surgical System
Study NCT02855892 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02855892 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02855892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GV1001
Study NCT05340283 — intervention group
Intervention type: PROCEDURE
Intervention: physiotherapy
Description: Patients received physiotherapy treatment at home for a certain period of time. Data were collected on the assessments made at the beginning and at the end of the physiotherapy treatment.
Study NCT03015415 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Elbow Open Arthrolyses
Description: Elbow arthrolysis by posterior access
Study NCT03015415 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-surgical intervention
Description: Rehabilitation with splinting protocols
Study NCT02463292 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT04203225 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel
Description: Topical anesthetic
Study NCT04203225 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel
Description: Topical anesthetic
Study NCT01529853 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR156597
Description: Pharmaceutical form: solution~Route of administration: subcutaneous
Study NCT04575415 — intervention group
Intervention type: DRUG
Intervention: Icotinib
Description: Icotinib 125mg three times a day
Study NCT04575415 — intervention group
Intervention type: DRUG
Intervention: Afatinib
Description: Afatinib 40 mg or clinical routine dose once daily
Study NCT04575415 — intervention group
Intervention type: DRUG
Intervention: Dacomitinib
Description: Dacomitinib 45mg or clinical routine dose once daily
Study NCT04575415 — intervention group
Intervention type: DRUG
Intervention: Osimertinib
Description: Osimertinib 80 mg once daily
Study NCT00029159 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: estrogen
Description: Participants were started on ethinyl estradiol at a daily dose of 50ng/kg at the beginning of the 3rd year of the study. The estrogen was continued until study end.
Study NCT00029159 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: estrogen
Description: Participants were started on ethinyl estradiol at a daily dose of 50ng/kg at the beginning of the 3rd year of the study. The estrogen was continued until study end.
Study NCT00029159 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: androgen
Description: Oxandrolone or placebo capsule, .06mg/kg/day, orally, for 2 years
Study NCT00029159 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: an inactive substance
Study NCT01113073 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ventilatory protocol
Description: Ventilatory protocol for short period with four different tidal volumes (12 min)
Study NCT01113073 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elastic band
Description: Placement of an elastic band around thorax to reduce thorax compliance
Study NCT01113073 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: passive leg raising test
Description: performing the passive leg raising test
Study NCT01079572 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: in-person
Description: Follow-up appointments will be completed in-person as per usual
Study NCT01079572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: web-based
Description: Patients who are at least 2 years following knee or hip replacement will complete a questionnaire online and routine x-rays at a PACS enabled imaging center. The patient's surgeon will receive an email from the database summarizing the patient's responses to key questions and will review the x-rays. The surgeon will determine whether the patient needs to be seen in-person.
Study NCT00273182 — intervention group
Intervention type: DEVICE
Intervention: InSync Model 8040
Description: Subjects with sucessful implants of InSync Model 8040.
Study NCT00273182 — intervention group
Intervention type: DEVICE
Intervention: InSync III Model 8042
Description: Subjects with successful implants of InSync III Model 8042
Study NCT03257540 — intervention group
Intervention type: DEVICE
Intervention: Small Bone Intramedullary Nail
Description: Patients undergoing a Lapidus Arthrodesis procedure for hallux valgus correction who are receiving a Phantom Small Bone Intramedullary nail will begin weight-bearing at 2 weeks and follow a pre-determined post-operative protocol.
Study NCT03968458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CON
Description: . Control condition without exercise / rest condition. The adolescents will be asked to remain quiet and at rest during the morning and will receive an ad libitum meal at lunch and dinner times. Their food reward will be assessed before and after lunch. Their appetite feelings will be assessed at regular intervals.
Study NCT03968458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EX-30
Description: Condition with an acute exercise set 30 minutes before lunch The adolescents will be asked to complete a 30 minutes exercise set at 65% of their capacities (cycling), 30 minutes before lunch. Lunch will be served ad libitum as well as diner. Their food reward will be assessed before and after lunch. Their appetite feelings will be assessed at regular intervals.
Study NCT03968458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EX-90
Description: condition with an acute exercise set 90 minutes before lunch. The adolescents will be asked to complete a 30 minutes exercise set at 65% of their capacities (cycling), 30 minutes before lunch. Lunch will be served ad libitum as well as diner. Their food reward will be assessed before and after lunch. Their appetite feelings will be assessed at regular intervals.
Study NCT01739530 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Repaircell
Description: allogenic differentiated adipocyte
Study NCT03009097 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DFDBA
Description: 13 intrabony defects in chronic periodontitis patients were treated with allograft (DFDBA)
Study NCT03009097 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DFDBA with atorvastatin
Description: 13 intrabony defects in chronic periodontitis patients were treated with allograft (DFDBA) in combination with atorvastatin gel
Study NCT03075644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: somapacitan
Description: Once weekly subcutaneous injections (s.c., under the skin)
Study NCT03075644 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norditropin
Description: Daily subcutaneous injections (s.c., under the skin)
Study NCT00696956 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Balloon angioplasty (uncoated conventional balloon)
Description: endovascular therapy
Study NCT00696956 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon angioplasty (conventional but coated with 3 µg/mm2 paclitaxel)
Description: endovascular therapy
Study NCT02957890 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Inactivated influenza vaccine (NH formulation)
Description: Round 1 (November): 0.5mL FluQuadri®, Sanofi Pasteur, containing 60μg antigen - 15μg for each influenza strain included - with strains recommended by the WHO for the northern hemisphere formulation
Study NCT02957890 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (NH formulation)
Description: Round 1 (November): 0.5mL FluQuadri®, Sanofi Pasteur, containing 60μg antigen - 15μg for each influenza strain included - with strains recommended by the WHO for the northern hemisphere formulation
Study NCT02957890 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (SH formulation)
Description: Round 2 (May): 0.5mL Vaxigrip®, Sanofi Pasteur, containing 45μg antigen - 15μg for each influenza strain included - with strains recommended by the WHO for the southern hemisphere formulation
Study NCT02957890 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Round 2 (May): 0.5mL normal saline